Trials / Completed
CompletedNCT04258189
A Study of JNJ-64417184, Administered as an Oral Solution, in Healthy Participants
A Phase 1, Randomized, Open-label, 4-Period Crossover Study in Healthy Subjects to Assess the Food Effect on a Single Dose of JNJ-64417184 Administered as an Oral Solution
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Janssen Research & Development, LLC · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the food effect on the single-dose pharmacokinetic (PK) of the JNJ-64417184 oral solution, administered as 2 different formulations, in healthy adult participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JNJ-64417184 | Single dose of JNJ-64417184 solution (with or without preservatives) will be administered orally. |
Timeline
- Start date
- 2020-02-11
- Primary completion
- 2020-08-05
- Completion
- 2020-08-05
- First posted
- 2020-02-06
- Last updated
- 2025-02-03
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04258189. Inclusion in this directory is not an endorsement.